TOVETUMAB
UNII 2XY62K75UV

Substance Identification & Data

This profile provides standardized clinical and technical data for Tovetumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2XY62K75UV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1243266-04-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2XY62K75UV

CAS Registry Number

1243266-04-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TOVETUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C82684

National Cancer Institute reference terminology for clinical and research data.

INN ID

9778

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-101

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tovetumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOVETUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR .ALPHA.) (HUMAN MONOCLONAL MEDI-575 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI-575 .KAPPA.-CHAIN, DIMER

TOVETUMAB [INN]

TOVETUMAB [USAN]

TOVETUMAB [WHO-DD]